Table 1. Demographic and clinical characteristics of the study population.
| Characteristic | Patients (49) N (%) |
|---|---|
| Sex | |
| Male | 44 (90) |
| Female | 5 (10) |
| Age (years) | |
| Median (range) | 55 (39–74) |
| <50 | 13 (27) |
| 50–59 | 24 (49) |
| 60–69 | 10 (20) |
| ≥70 | 2 (4) |
| Smoking history | |
| Never | 14 (29) |
| Former | 15 (31) |
| Current | 20 (41) |
| Tumor site | |
| Oropharynx | 41 (84) |
| Larynx | 4 (8) |
| Hypopharynx | 4 (8) |
| Staging | |
| III | 9 (18) |
| IVA | 30 (61) |
| IVB | 10 (20) |
| Tumor staging | |
| T1–2 | 16 (33) |
| T3 | 22 (45) |
| T4 | 10 (20) |
| Tx | 1 (2) |
| Lymph Node staging | |
| N0–1 | 11 (22) |
| N2 | 31 (63) |
| N3 | 7 (14) |
| HPV status (oropharynx only) | |
| Positive | 19 (46) |
| Negative | 7 (17) |
| Unknown | 15 (37) |
Demographic and clinicopathological characteristics of the entire patient population (N = 49).
Staging followed AJCC recommendations (6th edition).